[Clinical evaluation of ceftazidime in the field of pediatrics].
Clinical responses of ceftazidime (CAZ) in 13 cases of respiratory tract infections were excellent in 7 and good in 6, and those in 4 of urinary tract infections were excellent in 1 and good in 3. Clinical responses of CAZ in 3 cases of acute gastroenteritis were good in 1 and fair in 2. CAZ was considered to be effective both in respiratory and urinary tract infections; however, CAZ did not seem to be very effective clinically in gastrointestinal infections. As to side effects, slight elevation of GOT was observed in 3 cases and skin rash in 1 case, but all these abnormalities were mild and transient.
D000367:Age Factors; D002442:Ceftazidime; D002511:Cephalosporins / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation; D005260:Female; D005759:Gastroenteritis / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D012141:Respiratory Tract Infections / Q000188:drug therapy*; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002511:Cephalosporins; D002442:Ceftazidime